Edges in Network
| Network | GSE16391_top8000 - GSE16391 - SiGN-BN NNSR |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | FGF19 |
| Upstream (Parents) |
|---|
| (<<) ATG16L2 → FGF19 |
| (<<) BDNF → FGF19 |
| (<<) MAMLD1 → FGF19 |
| (<<) KRT31 → FGF19 |
| (<<) OLA1 → FGF19 |
| (<<) KRT33A → FGF19 |
| Downstream (Children) |
|---|
| FGF19 → SPEF2 (>>) |
| FGF19 → BDNF (>>) |
| FGF19 → C4orf47 (>>) |
| FGF19 → EFNB3 (>>) |
| FGF19 → WNK3 (>>) |
| FGF19 → MAMLD1 (>>) |
| FGF19 → PON1 (>>) |
| FGF19 → NMU (>>) |
| FGF19 → RNF157 (>>) |
| FGF19 → C20orf26 (>>) |
| FGF19 → MPZL3 (>>) |
| FGF19 → KRT33A (>>) |
| FGF19 → RPS28 (>>) |
